Anika Therapeutics (ANIK) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Anika Therapeutics Reports First-Quarter 2015 Financial Results
April 28, 2015 4:05 PM EDTProduct Revenue Grows 8% to $15.5 Million
U.S. Monovisc® Reaching 3% Market Share in Q1 2015
Company Continues Clinical, Regulatory and Commercial Advancements
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (HA) technology, today reported financial results for the quarter ended... More
